2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Deepa Jagadeesh: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ME-401 and R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma ME-401, Rituximab, Cyclophosphamide - Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | Terminated | Deepa Jagadeesh | 13 | 2021-04-28 | 2025-02-07 |
| Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder Rituximab, Acalabrutinib, CT scans - Post-transplant Lymphoproliferative Disorder | Phase 2 | Terminated | Deepa Jagadeesh | 6 | 2020-09-02 | 2024-04-10 |
Lymphoma, Large B-Cell, Diffuse (1)
Rituximab (2) · Cyclophosphamide (1) · Doxorubicin (1) · ME-401 (1) · Prednisone (1) · Tomography, X-Ray Computed (1) · Vincristine (1) · acalabrutinib (1)
United States (2)